Buscar resultados de ensayos clínicos
Leukemia, T-Cell - 50 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia Condición: Leukemia, T-Cell Fecha: 2004-11-03 Intervenciones: Drug: forodesine hydrochloride (BCX-1777) |
Active, not recruiting |
Nombre del estudio: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) Condición: Adult T-cell Leukemia-Lymphoma Fecha: 2012-06-19 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia Condición: Adult T-Cell Leukemia (ATL) Fecha: 2009-06-17 Intervenciones:
|
Completed |
Nombre del estudio: Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac Condición:
Fecha: 1999-11-03 Intervenciones: Drug: Yttrium-90 radiolabeled anti-Tac antibody |
Completed |
Nombre del estudio: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma Condición: Adult T-cell Leukemia-lymphoma Fecha: 2009-06-09 Intervenciones: Biological: KW-0761 KW-0761 is administered weekly for 8 weeks as an intravenous infusion of 2 hours at |
Completed |
Nombre del estudio: Lenalidomide in HTLV-1 Adult T-Cell Leukemia Condición: Adult T Cell Leukemia/Lymphoma Fecha: 2011-01-10 Intervenciones: Drug: Lenalidomide 25mg or 10mg (based on creatinine clearance) once daily for days 1-21 of a 28 day cyc |
Active, not recruiting |
Nombre del estudio: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma Condición: Adult T-Cell Leukemia-Lymphoma Fecha: 2012-11-07 Intervenciones: Drug: Lenalidomide 25 mg of Lenalidomide administered orally once daily |
Completed |
Nombre del estudio: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma Condición: Acute T-Cell Leukemia-Lymphoma Fecha: 2003-05-20 Intervenciones: Biological: Alemtuzumab Infusion of Campath-1H 3 mg on day # 1, 10 mg on day #2, and 30 mg day # 3 follo |
Recruiting |
Nombre del estudio: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma Condición:
Fecha: 2016-04-10 Intervenciones:
|
Recruiting |
Nombre del estudio: Ruxolitinib for Adult T-Cell Leukemia Condición:
|